These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


683 related items for PubMed ID: 3761438

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Long-term followup of patients treated with 1 or 2, 6-week courses of intravesical bacillus Calmette-Guerin: analysis of possible predictors of response free of tumor.
    Coplen DE, Marcus MD, Myers JA, Ratliff TL, Catalona WJ.
    J Urol; 1990 Sep; 144(3):652-7. PubMed ID: 2388321
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Experience with bacillus Calmette-Guerin in patients with superficial bladder carcinoma.
    Brosman SA.
    J Urol; 1982 Jul; 128(1):27-30. PubMed ID: 6809960
    [Abstract] [Full Text] [Related]

  • 9. Long-term effect of intravesical bacillus Calmette-Guerin on flat carcinoma in situ of the bladder.
    Herr HW, Pinsky CM, Whitmore WF, Sogani PC, Oettgen HF, Melamed MR.
    J Urol; 1986 Feb; 135(2):265-7. PubMed ID: 3511284
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prognostic factors in patients treated with intravesical bacillus Calmette-Guerin for superficial bladder cancer.
    Torrence RJ, Kavoussi LR, Catalona WJ, Ratliff TL.
    J Urol; 1988 May; 139(5):941-4. PubMed ID: 3361668
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Superficial bladder cancer treated with bacillus Calmette-Guerin: a multivariate analysis of factors affecting tumor progression.
    Herr HW, Badalament RA, Amato DA, Laudone VP, Fair WR, Whitmore WF.
    J Urol; 1989 Jan; 141(1):22-9. PubMed ID: 2908949
    [Abstract] [Full Text] [Related]

  • 18. Bacillus Calmette-Guerin for treatment of superficial transitional cell carcinoma of the bladder in patients who have failed thiotepa and/or mitomycin C.
    Soloway MS, Perry A.
    J Urol; 1987 May; 137(5):871-3. PubMed ID: 3106653
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prospective randomized comparison of intravesical with percutaneous bacillus Calmette-Guerin versus intravesical bacillus Calmette-Guerin in superficial bladder cancer.
    Lamm DL, DeHaven JI, Shriver J, Sarosdy MF.
    J Urol; 1991 Apr; 145(4):738-40. PubMed ID: 2005691
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 35.